The study of the effect of frequent measurement of diabetes-related biomarkers in tears
Not Applicable
- Conditions
- diabetes
- Registration Number
- JPRN-UMIN000041903
- Lead Sponsor
- The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Participants who use insulin and GLP-1 Participants positive for HIV, hepatitis C, syphilis Participants determined to be difficult to continue the study by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link tear biomarkers to diabetes progression and management?
How does tear-based biomarker monitoring compare to traditional blood tests in diabetes management?
Which specific diabetes-related biomarkers in tears are most predictive of treatment response and disease activity?
What adverse events are associated with frequent tear sampling for biomarker analysis in diabetes patients?
Are there combination approaches or competitor drugs leveraging tear biomarkers for diabetes diagnosis or monitoring?